AT-RvD1 caused pronounced and long-lasting analgesic effects in a model of adjuvant-induced arthritis in rats through inhibition of proinflammatory and pronociceptive mediators, including IL-1β, and through the blockage of COX-2 mRNA expression and NF-kB activation [12]. Here, PTGS2 is linked to arthritic joint disease.